Why is $EVMN stock up today?
Evommune, Inc.
Why is $EVMN up today?
The likely driver
Evommune, Inc.: Evommune Initiates Phase 2b Clinical Trial of MRGPRX2 Inhibitor EVO756 in Migraine Prophylaxis
SEC EDGAR·8:01 AM ET
Price
$13.18
Move today
+1.3%
Volume vs avg
0.0x
Scanner alerts today
0
Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.